Trager James
Chief Scientific Officer at NKTX
- Sold, on record
- $667k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jun 18, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NKTXNkarta, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NKTXPlan not statedAug 2, 2021 2021
Sold 3,600 shares at $31.53 ($114k)
Trager James, Chief Scientific Officer
Sold 7.5% of holdings ($1.5M position)44,372 shares leftFiling
- 2 Form 4 sale NKTXPlan not statedAug 15, 2022 +378 days
Sold 5,000 shares at $17.53 ($88k)
Trager James, Chief Scientific Officer
Sold 7.4% of holdings ($1.2M position)62,172 shares left1.4x usual sizeFiling
- 3 Form 4 sale NKTXPlan not statedJan 17, 2023 +155 days
Sold 1,115 shares at $5.49 ($6k)
Trager James, Chief Scientific Officer
Sold 1.1% of holdings ($547k position)98,557 shares left0.3x usual sizeFiling
- 4 Form 4 sale NKTXNo planJun 20, 2023 +154 days
Sold 439 shares at $4.85 ($2k)
Trager James, Chief Scientific Officer
No 10b5-1 planSold 0.4% of holdings ($488k position)100,118 shares left0.1x usual sizeFiling
- 5 Form 4 sale NKTXUnusualJan 16, 2024 +210 days
Sold 4,560 shares at $8.74 ($40k)
Trager James, Chief Scientific Officer
No 10b5-1 planSold 2.9% of holdings ($1.4M position)153,558 shares left4.1x usual sizeFiling
- 6 Form 144 notice NKTXNoticeFeb 12, 2024 +27 days
Filed to sell 4,143 shares ($46k)
Trager James, Officer
10b5-1 plan1.5x usual sizeFiling
- 7 Form 4 sale NKTXNo planFeb 12, 2024 same day
Sold 4,143 shares at $12.00 ($50k)
Trager James, Chief Scientific Officer
No 10b5-1 planSold 2.7% of holdings ($1.8M position)149,415 shares left1.5x usual sizeFollows a Form 144Filing
- 8 Form 4 sale NKTXNo planJun 18, 2024 +127 days
Sold 456 shares at $5.60 ($3k)
Trager James, Chief Scientific Officer
No 10b5-1 planSold 0.3% of holdings ($848k position)150,959 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Jun 20, 2024 | NKTX | Chief Scientific Officer | Form 4 sale | 456 | $3k | 0.3% | No plan | SEC |
| Feb 12, 2024 | Feb 14, 2024 | NKTX | Chief Scientific Officer | Form 4 sale | 4,143 | $50k | 2.7% | No plan | SEC |
| Feb 12, 2024 | Feb 12, 2024 | NKTX | Officer | Form 144 notice | 4,143 | $46k | Notice | SEC | |
| Jan 16, 2024 | Jan 18, 2024 | NKTX | Chief Scientific Officer | Form 4 sale | 4,560 | $40k | 2.9% | Unusual | SEC |
| Jun 20, 2023 | Jun 22, 2023 | NKTX | Chief Scientific Officer | Form 4 sale | 439 | $2k | 0.4% | No plan | SEC |
| Jan 17, 2023 | Jan 18, 2023 | NKTX | Chief Scientific Officer | Form 4 sale | 1,115 | $6k | 1.1% | Plan not stated | SEC |
| Aug 15, 2022 | Aug 17, 2022 | NKTX | Chief Scientific Officer | Form 4 sale | 5,000 | $88k | 7.4% | Plan not stated | SEC |
| Aug 2, 2021 | Aug 4, 2021 | NKTX | Chief Scientific Officer | Form 4 sale | 3,600 | $114k | 7.5% | Plan not stated | SEC |
| May 3, 2021 | May 5, 2021 | NKTX | Chief Scientific Officer | Form 4 sale | 3,600 | $114k | 7.3% | Plan not stated | SEC |
| Feb 2, 2021 | Feb 3, 2021 | NKTX | Chief Scientific Officer | Form 4 sale | 6,400 | $251k | 12.0% | Plan not stated | SEC |